차백신연구소

261780KOSDAQ자연과학 및 공학 연구개발업

43.5 / 100

Reference Date: 2026-04-13

Financial Score9.0 / 40

News Sentiment12.5 / 25

Momentum8.0 / 20

Disclosure14.0 / 15

AI Analysis: Revenue is on a declining trend, Operating Profit is on a declining trend. Rose 5.7% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Chabaksin Research Institute is a biotech company specializing in the development of vaccines and immunotherapies using advanced technologies such as virus-like particles (VLP), liposomes, and immune checkpoint inhibitors (ICI). The company focuses on immunological research, antigen presentation, and apoptosis-related mechanisms to develop new drugs for infectious diseases and cancer.

Number of Employees

49people

Average Salary

63.4M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 120.074.0Point

PBR

7.52Industry Average 3.821.0Point

2.0x industry avg (risky)

ROE

-81.07Industry Average -32.113.5Point

2.5x industry avg (excellent)

Debt Ratio

14.65Industry Average 7.520.5Point

1.9x industry avg (risky)

Trend 2023~20250.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼15.6% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼52.7% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -39.4% (declining, 3yr)

Detailed News Sentiment

1 totalPositive 0Neutral 1Negative 0Average Sentiment Score 50

Neutral
차백신연구소 인수한 소룩스, 시행 사업까지 진출… 사업 다각화 잰걸.....
차백신연구소를 인수한 소룩스가 남이섬과 업무협약을 맺고 시행 사업까지 진출하며 사업 다각화를 추진하고 있으나, 차백신연구소 자체의 사업 내용과는 직접적인 관련이 없습니다.

Detailed Momentum

52-week position3.0Point

52w lower range (26%)

Current 3,320Won52-week high 5,70052-week low 2,480

1-month return4.0Point

1m +5.73% (slight rise)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

13 totalPositive 2Neutral 11Negative 0

Neutral전환사채(해외전환사채포함)발행후만기전사채취득2026-04-10
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-01
Neutral전환사채(해외전환사채포함)발행후만기전사채취득2026-03-26
Neutral주식등의대량보유상황보고서(일반)2026-03-25
Neutral주식등의대량보유상황보고서(약식)2026-03-25